NeuroPace | 8-K: Current report
NeuroPace | 8-K: NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
NeuroPace | DEFA14A: Others
NeuroPace | DEF 14A: Definitive information statements
NeuroPace | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
NeuroPace | 8-K: Current report
NeuroPace | 8-K: Current report
NeuroPace | 8-K: Current report
NeuroPace | 8-K: Current report
NeuroPace | 8-K: NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
NeuroPace | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
NeuroPace | 8-K: NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
NeuroPace | 8-K: Current report
NeuroPace | 8-K: Current report
NeuroPace | 8-K: Current report
NeuroPace | 8-K: NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
NeuroPace | DEFA14A: Others
NeuroPace | DEF 14A: Definitive proxy statements
NeuroPace | 8-K: Current report
NeuroPace | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data